|4 BIOTECH STOCKS INSIDERS ARE SELLING!$FGEN $DCPH $RAPT $SGTXInsider selling cannot be the||
||10/12/2021 8:01:04 AM|
|4 BIOTECH STOCKS FACING FDA REJECTION!Is it a full stop or a pause to their journey?SESN FGEN SPPI A||
||08/23/2021 7:16:52 PM|
|$FGEN wow what a great product. This is a PILL that will replace epoetin injections and venefer whic||
||11/08/2019 5:08:24 PM|
|$FGEN Back over $44 on 4 million shares.||
||11/08/2019 3:18:24 PM|
|$FGEN Not looking good after resumption.||
||11/08/2019 2:30:23 PM|
FibroGen Inc Company Name:
FGEN Stock Symbol:
FibroGen Inc Website:
News, Short Squeeze, Breakout and More Instantly...
Completed enrollment of LELANTOS-2 Phase 3 study of pamrevlumab in ambulatory patients with Duchenne muscular dystrophy 2Q 2022 revenue of $29.8 million, growth of 22% vs. 2Q 2021 Continued significant roxadustat volume growth in China SAN F...
FIBROGEN INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Provides Update of its Investigation of the Officers and Directors of FibroGen, Inc. - FGEN FIBROGEN INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & F...
SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its second quarter 2022 financial results on Monday, August 8 after the market close. FibroGen will also conduct a conference call on that day at 5:00 p.m. ET (2:00 p.m. PT) with the investment comm...